Skip to main content

Table 4 Model for predicting total number of LNs

From: Clinical study of harvesting lymph nodes with carbon nanoparticles in advanced gastric cancer: a prospective randomized trial

Model

β

SE

t

p

Constanta

11.628

7.839

1.483

0.164

CNP-staining LNs

1.062

0.329

3.223

0.007

Metastatic LNs

2.373

1.126

0.475

0.035

R square

 

0.537

  

Sample size

 

15

  
  1. Dependent variable: number of lymph nodes (Y); predictors: constant, CNP-staining LNs (X1), metastatic LNs (X2)
  2. aGender, age, BMI, location, surgery, operation time, bleeding, diameter, and pathological stage were included